[Lecture Report] The 10th NIKKEI FT Communicable Diseases Conference (Nikkei Inc., October 16-18, 2023, Tokyo, Chiyoda-ku)
date : 12/7/2023
Tags: AMR, Global Health, Vaccinations
On October 16-18, 2023, HGPI Chairman Dr. Kiyoshi Kurokawa, CEO and Board Member Mr. Ryoji Noritake, and Vice President Mr. Joji Sugawara spoke at various programs throughout each day of the 10th NIKKEI FT Communicable Diseases Conference, organized by Nikkei Inc. and co-sponsored by Financial Times.
For details, please visit the event website, which can be found here.
Below is an excerpt from the program that included Dr. Kurokawa and Mr. Noritake, Mr. Sugawara.
October 17 (Tue)
Special Session 1 Establishing a Drug Discovery Ecosystem for Infectious Disease Area – A Year in Review and Future Initiatives –
Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)
Special Session 2 Importance of Novel Antibacterial Drugs, and Global Collaboration for Expansion of Necessary Pull-type Incentives
Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)
Agenda 4 – Making Unpredictable Communicable Disease Predictable by Economic Incentives and R&D
Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)
Breakout Session D Significance and Challenges of Infectious Diseases Control in Companies
Discusser: Joji Sugawara (Vice President, Health and Global Policy Institute)
October 18 (Wed)
Special Session 4 Making Breakthroughs With Japan -Toward Accelerating Open Innovation in Japan-
Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)
Summary Session / Conclusion / Statement
Panelist:
Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)
Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)
日本語
Top Research & Recommendations Posts
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Announcement] HGPI Joins Alliance for Transformative Action on Climate and Health (April 22, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-30
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Community Development for Senior Health: From Establishing Evidence to Social Implementation” (April 23, 2024)
-
2024-05-01
[Registration Open] The Global Health Education Program (G-HEP) 2024 (May 1, 2024)
-
2024-05-09
[Registration Open] The Health Policy Academy the 13th Session